EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Weight management using meal replacements and cardiometabolic risk reduction in individuals with pre‐diabetes and features of metabolic syndrome: A systematic review and meta‐analysis of randomized controlled trials

Jarvis C Noronha, Stephanie K Nishi, Tauseef A Khan, Sonia Blanco Mejia, Cyril W C Kendall, Hana Kahleová, Dario Rahelić, Jordi Salas-Salvadó, Lawrence A Leiter, Michael E J Lean, John L Sievenpiper iD

Obesity Reviews · 2024

DOI: 10.1111/obr.13751 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Obesity Reviews, 2024. Verfasst von Jarvis C Noronha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Ont…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Randomized Controlled Trials as Topic, Weight Loss, Prediabetic State. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Diabetes and Nutrition Study Group (DNSG) of the European Association of the Study of Diabetes (EASD), Canada Foundation for Innovation (CFI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review synthesized the evidence from randomized controlled trials comparing the effect of meal replacements (MRs) as part of a weight loss intervention with conventional food‐based weight loss diets on cardiometabolic risk in individuals with pre‐diabetes and features of metabolic syndrome. MEDLINE, EMBASE, and Cochrane Library were searched through January 16, 2024. Data were pooled using the generic inverse variance method and expressed as mean difference [95% confidence intervals]. The overall certainty of the evidence was assessed using GRADE. Ten trials ( n = 1254) met the eligibility criteria. MRs led to greater reductions in body weight (−1.38 kg [−1.81, −0.95]), body mass index (BMI, −0.56 kg/m 2 [−0.78, −0.34]), waist circumference (−1.17 cm [−1.93, −0.41]), HbA 1c (−0.11% [−0.22, 0.00]), LDL‐c (−0.18 mmol/L [−0.28, −0.08]), non‐HDL‐c (−0.17 mmol/L [−0.33, −0.01]), and systolic blood pressure (−2.22 mmHg [−4.20, −0.23]). The overall certainty of the evidence was low to moderate owing to imprecision and/or inconsistency. The available evidence suggests that incorporating MRs into a weight loss intervention leads to small important reductions in body weight, BMI, LDL‐c, non‐HDL‐c, and systolic blood pressure, and trivial reductions in waist circumference and HbA 1c , beyond that seen with conventional food‐based weight loss diets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeRandomized Controlled Trials as TopicWeight LossPrediabetic StateHumansMealsDiet, ReducingCardiometabolic Risk FactorsCardiovascular DiseasesRisk Reduction Behavior

Stichwörter der Autor:innen

meal replacementsmetabolic syndromeprediabetesweight management

Autor:innen und Institutionen

  • Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Toronto, Ontario, Canada.
  • School of Medicine, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Alimentació, Nutrició, Desenvolupament i Salut Mental ANUT-DSM, Reus, Spain.
  • Alimentació, Nutrició, Desenvolupament i Salut Mental, Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.
  • Centro de Investigación Biomédica en Red Fisiopatología de La Obesidad y La Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: John L Sievenpiper

Förderung

  • CIHR
  • Diabetes and Nutrition Study Group (DNSG) of the European Association of the Study of Diabetes (EASD)
  • Canada Foundation for Innovation (CFI)
  • Ministry of Research and Innovation's Ontario Research Fund (ORF)
  • Toronto 3D Internship award
  • PSI Graham Farquharson Knowledge Translation Fellowship, Diabetes Canada Clinician Scientist award
  • CIHR INMD/CNS New Investigator Partnership Prize
  • Banting & Best Diabetes Centre Sun Life Financial New Investigator Award

Zitieren

APA

Noronha, J. C., Nishi, S. K., Khan, T. A., Blanco Mejia, S., Kendall, C. W. C., Kahleová, H., Rahelić, D., Salas-Salvadó, J., Leiter, L. A., Lean, M. E. J., & Sievenpiper, J. L. (2024). Weight management using meal replacements and cardiometabolic risk reduction in individuals with pre‐diabetes and features of metabolic syndrome: A systematic review and meta‐analysis of randomized controlled trials. Obesity Reviews. https://doi.org/10.1111/obr.13751

Vancouver

Noronha JC, Nishi SK, Khan TA, Blanco Mejia S, Kendall CWC, Kahleová H, et al. Weight management using meal replacements and cardiometabolic risk reduction in individuals with pre‐diabetes and features of metabolic syndrome: A systematic review and meta‐analysis of randomized controlled trials. Obesity Reviews. 2024. doi:10.1111/obr.13751

BibTeX
@article{Noronha2024,
  author = {Noronha, Jarvis C and Nishi, Stephanie K and Khan, Tauseef A and Blanco Mejia, Sonia and Kendall, Cyril W C and Kahleová, Hana and Rahelić, Dario and Salas-Salvadó, Jordi and Leiter, Lawrence A and Lean, Michael E J and Sievenpiper, John L},
  title = {Weight management using meal replacements and cardiometabolic risk reduction in individuals with pre‐diabetes and features of metabolic syndrome: A systematic review and meta‐analysis of randomized controlled trials},
  journal = {Obesity Reviews},
  year = {2024},
  doi = {10.1111/obr.13751}
}
Kostenlos starten →